Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals is a biotechnology company focused on developing drugs for the treatment of genetic diseases, characterized by the overproduction of one or more proteins. Its medical solutions target disease-causing genes. Its product portfolio includes drugs for hepatitis B, Alpha-1 Antitrypsin deficiency, thrombosis and angioedema, clear cell carcinoma and renal cell carcinoma, as well as cardiovascular diseases.